The disclosure describes nanocarried andor microcarried jasmonate compounds and their pharmaceutical compositions, as well as use thereof for treating or preventing angiogenesis-related or NF-\u03baB-related disorders. The medium contains at least two acids, where the difference in pKa values of adjacent acids are no greater than 1. A color of the envelope is different from that of the light emitted by the LED module. The signaling overhead of the proposed approach can be of the same order as that of a hard signaling approach. Alerts are generated and delivered when the traffic and weather alert conditions are satisfied.